How Novo’s Acquisition Of Catalent Cleared European Regulators

 
• By Francesca Bruce
  
Pink Sheet Perspectives 2025
Novo's acquisition of Catalent was formalized at the end of 2024 (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Manufacturing

More from North America